Sign in
4

Changes in Ownership

FATE THERAPEUTICS INC Filed Acc 0001193125-26-271088

Options or other derivatives

  • Director acquired 87,900 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Jooss Karin Director 2026-06-12 Grant or award · Stock Option (Right to Buy) +87,900 87,900 D: show line 1 in the form
Loading xslF345X06/ownership.xml…